View Section: Cash Flow Statement
ML
MoonLake ImmunotherapeuticsNASDAQ MLTX Stock Report
Last reporting period 30 Sep, 2023
Updated 19 Sep, 2024
Last price
—
Market cap $B
3.207
Middle
Exchange
XNAS - Nasdaq
ML
Last reporting period 30 Sep, 2023
Updated 19 Sep, 2024
Last price
—
Market cap $B
3.207
Exchange
XNAS - Nasdaq
ML
Ex-dividend date
Amount
Share price
Yield
This ticker has no dividend history